If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

Thu, 24th Sep 2020 16:35

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

Supply@Me Capital PLC - fintech platform which provides inventory monetisation - Chief Executive Officer Alessandro Zamboni - via Orchestra Group, which he owns - on Wednesday buys option to receive 630.0 million shares if share price is above 0.6945 pence on December 31. The option costs GBP1.1 million. Supply@Me's current share price is 0.5100p, down from 1.1000p in March but up from 0.0500p in August. Supply@Me separately says Orchestra Group holds 27.89% of the company. On Monday, Supply@Me said it had entered into strategic pact with a "leading European alternative investment firm" and shareholders 1AF2 Srl and AvantGarde Group SpA to acquire a bank in Europe. Supply@Me to give the bank rights to invest in securitisation note issues and in exchange, the bank will provide up to EUR8 billion of funding over five years. Supply@Me will not be shareholder in bank and will bear no costs related to the transaction. Milan-based Supply@Me reversed into AIM stock Abal Group PLC and relisted on the London Main Market back in March.

----------

WPP PLC - London-based advertising and marketing group - CEO Mark Read buys 85,000 shares at GBP5.67 on Thursday, and Chief Financial Officer John Rogers buys 75,838 shares at GBP5.88 on Wednesday. Together worth GBP928,209.

----------

Funding Circle Holdings PLC - London-based platform for investors to lend to small businesses - CEO Samir Desai buys 163,017 shares at average GBP0.62, worth GBP101,098, on Thursday. Funding Circle on Thursday posted a GBP115.1 million pretax loss for the six months ended June 30, dramatically widened from a GBP30.8 million loss a year before.

----------

Beazley PLC - London-based specialist insurance - Non-Executive Director Andrew Likierman buys 10,000 shares at 326.05 pence, worth GBP32,605, on Wednesday.

----------

Polymetal International PLC - Non-Executive Director Konstantin Yanakov buys 2,421 shares at RUB1,649.02, worth RUB4.0 million, about GBP40,465, on Tuesday.

----------

eve Sleep PLC - London-based direct-to-consumer mattress retailer - CEO Cheryl Calverley buys 92,785 shares at average 4.85p, worth GBP4,500, on Tuesday. Now has 280,285 shares.

----------

Fusion Antibodies PLC - Belfast-based antibody engineering for therapeutic drug and diagnostic applications - Non-Executive Director Alan Mawson sells 20,000 shares at 180p, worth GBP36,000, on Wednesday. Still has 124,000 shares, an 0.5% stake.

----------

SIG PLC - London-based supplier of specialist construction products - CEO Stephen Francis buys 208,000 shares at 24.0p and Susan Allner, associate of Chair Andrew Allner, buys 40,000 shares at 24.1p, both on Thursday and together worth GBP59,520.

----------

Sanne Group PLC - London-based fund and corporate services - Non-Executive Director Yves Stein buys 5,000 shares at GBP5.80, worth GBP29,000, on Wednesday.

----------

WANdisco PLC - Sheffield, England and San Ramon, California-based cloud-based data management platform - Non-Executive Director Grant Dollens buys 200,000 shares via Global Frontier Partners LP at average GBP4.48, worth GBP896,000, on Wednesday. Now has 2.4 million shares, a 4.5% stake.

----------

Dechra Pharmaceuticals PLC - Cheshire-based veterinary products - Tony Griffin, managing director of Dechra Veterinary Products EU, sells 4,400 shares at GBP32.03, worth GBP140,915, on Wednesday. Still has 70,650 shares.

----------

Workspace Group PLC - London-based office and studio space provider - CFO Dave Benson buys 19,850 shares at 501.18p, worth GBP99,485, on Wednesday. Benson joined Workspace from Premier Inn-owner Whitbread PLC in April.

----------

Caledonia Mining Corp PLC - southern Africa-focused exploration and development company - Chair Leigh Wilson sells 12,000 shares at USD17.32, worth USD207,840, on Tuesday. Still has 40,000 shares.

----------

Gresham House Strategic PLC - investor in smaller UK public companies - Chair David Potter buys 2,526 shares at 989p, worth GBP24,982, on Tuesday. He now has 24,882 shares. Three other non-executive directors buy a total 4,440 at 979p, also on Tuesday.

----------

Yourgene Health PLC - Manchester-based molecular diagnostics - Chair Adam Reynolds buys 294,117 shares and CEO Lyn Rees buys 294,000 shares, both at 17p and together worth GBP99,980, on Wednesday. Reynolds now has 6.7 million shares and Rees 1.0 million. Three Yourgene directors had bought a total of 205,260 shares on Tuesday.

----------

Maestrano Group PLC - London-based cloud platform for data management and business analytics - Three directors - John David, Jonathan Macleod and Nicholas McInnes - each buy 150,000 shares at 10p, together worth GBP45,000, on Wednesday. The purchases were part of 1.7 million shares sold by David Israel in order to reduce the holding of the concert party of which he is a member down to 46.7% from 47.8%. Maestrano says the concert party had "inadvertently" triggered the obligation to make a general offer for the company back in March. In compensation for reducing his stake, Israel is issued an equivalent number of share options.

----------

TI Fluid Systems PLC - Oxford-based products that store and move fluids such as fuel and brake fluid around automobiles - Independent Non-Executive Director John Smith buys 40,300 shares at GBP1.35, worth GBP54,292, on Tuesday.

----------

Rosslyn Data Technologies PLC - London-based cloud enterprise data analytics platform - Founder & Chief Information Officer Hugh Cox buys 110,000 shares at 5.89p, worth GBP6,479, on Wednesday. Now has 11.5 million shares, a 3.4% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 16:56

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.